Literature DB >> 2940286

Atrial pressure and secretion of atrial natriuretic factor into the human central circulation.

R J Rodeheffer, I Tanaka, T Imada, A S Hollister, D Robertson, T Inagami.   

Abstract

Atrial natriuretic factor, a peptide found in mammalian cardiac atria, has natriuretic and vasodilatory properties that may be important in the regulation of intravascular volume. To study factors related to its release in human subjects, intracardiac pressures and plasma atrial natriuretic factor concentrations in the central circulation were measured in 34 patients with a variety of cardiovascular disorders. Plasma atrial natriuretic factor concentration increased from the inferior vena cava to the right atrium (76 +/- 24 to 162 +/- 37 pg/ml, p less than 0.001) and from the vena cava to the aorta (76 +/- 24 to 177 +/- 46 pg/ml, p less than 0.001). Mean right atrial pressure was positively correlated with atrial natriuretic factor concentration in the pulmonary artery (r = 0.58, p less than 0.001), and mean pulmonary capillary wedge pressure was positively correlated with concentration in the aorta (r = 0.64, p less than 0.001). In six patients whose atrial natriuretic factor concentrations were measured at two different levels of atrial pressure, increased atrial pressure was accompanied by increased atrial natriuretic factor concentration in the pulmonary artery (p less than 0.01) and aorta (p less than 0.01). Atrial natriuretic factor levels measured in fresh myocardium from a patient undergoing cardiac transplantation showed tissue concentrations in the atria 500-fold higher than tissue concentrations in the ventricles. These data document that atrial natriuretic factor is found in human atrial myocardium and suggest that it may be released in response to increased atrial pressure. Such a secretory release mechanism is consistent with the hypothesis that atrial natriuretic factor plays a role in the regulation of circulatory volume.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940286     DOI: 10.1016/s0735-1097(86)80086-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  [Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].

Authors:  K H Scholz; J Marten; C Herrmann; U Spaar; U Tebbe; K L Neuhaus; H Kreuzer
Journal:  Klin Wochenschr       Date:  1990-08-17

2.  The effect of iron overload in the hearts of patients with beta-thalassemia.

Authors:  S V Brili; A I Tzonou; S S Castelanos; C J Aggeli; C A Tentolouris; C E Pitsavos; P K Toutouzas
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

3.  Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.

Authors:  A Sugawara; K Nakao; N Morii; T Yamada; H Itoh; S Shiono; Y Saito; M Mukoyama; H Arai; K Nishimura
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

4.  Plasma concentrations of atrial natriuretic peptide in patients with artificial and transplanted hearts.

Authors:  G Deray; G Maistre; P Cacoub; A Carayon; P Leger; J Rottembourg; M Anouar; P Sassano; C Cabrol
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.

Authors:  Krishna K Gaddam; Mari K Nishizaka; Monique N Pratt-Ubunama; Eduardo Pimenta; Inmaculada Aban; Suzanne Oparil; David A Calhoun
Journal:  Arch Intern Med       Date:  2008-06-09

7.  Atrial natriuretic peptide concentrations in pre-eclampsia.

Authors:  J K Thomsen; T L Storm; G Thamsborg; M de Nully; B Bødker; S Skouby
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

8.  Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.

Authors:  H Yasue; K Obata; K Okumura; M Kurose; H Ogawa; K Matsuyama; M Jougasaki; Y Saito; K Nakao; H Imura
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

9.  Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels.

Authors:  E D Kharasch; K T Yeo; M A Kenny; D W Amory
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

10.  Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

Authors:  A S Hollister; R J Rodeheffer; F J White; J R Potts; T Imada; T Inagami
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.